Page 7 - ஆர்யா அறிவியல் கையகப்படுத்தல் கார்ப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
SHAREHOLDER ALERT: WeissLaw LLP Reminds ARYA, GLUU, AJRD and RP Shareholders About Its Ongoing Investigations
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
SHAREHOLDER ALERT: WeissLaw LLP Reminds ARYA, GLUU, AJRD and RP Shareholders About Its Ongoing Investigations
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Arya Sciences Acquisition Corp. III ("ARYA" or the "Company") (NASDAQ: ARYA) in connection with the Company's proposed merger with Nautilus Biotechnology, Inc. ("Nautilus"), a privately-held startup mapping human proteins. Under the terms of the merger agreement, ARYA will acquire Nautilus through a reverse merger that will result in Nautilus becoming a becoming a public company traded on the NASDAQ. The transaction implies an enterprise value for the combined company of approximately $350 million.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III
February 8, 2021 GMT
SEATTLE & NEW YORK (BUSINESS WIRE) Feb 8, 2021
Nautilus Biotechnology, Inc. (“Nautilus Biotechnology” or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the human proteome, and Arya Sciences Acquisition Corp III (Nasdaq: ARYA) (“Arya III”), a special purpose acquisition company or
SPAC, sponsored by Perceptive Advisors, today announced they have entered into a definitive business combination agreement. Upon closing of the transaction, Arya III will redomicile as a Delaware corporation, be renamed Nautilus Biotechnology, Inc. and its common stock is expected to be listed on Nasdaq under the ticker symbol “NAUT” (the “Combined Company”).
Jeff Bezos-backed startup Nautilus Biotechnology set to go public via SPAC at $900M valuation
February 9, 2021 at 10:12 am
Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. (Nautilus Photo)
Nautilus Biotechnology, a Seattle-based biotech startup led by Isilon co-founder Sujal Patel, is the latest company to go public using a special purpose acquisition company, or SPAC.
The deal, announced Monday morning, will inject approximately $350 million into Nautilus, which is developing a next-generation platform to analyze the human proteome, or the body’s full set of proteins. It values the company at $900 million.
The company plans to raise $150 million as part of a merger with Arya Sciences Acquisition Corp III, a publicly-traded SPAC sponsored by existing Nautilus investor Perceptive Advisors. As part of the transaction, Nautilus will also reel in $200 million from new and previous backers via private investments in public equity, also known as a common stoc
vimarsana © 2020. All Rights Reserved.